2018
DOI: 10.1016/j.cgh.2017.11.031
|View full text |Cite
|
Sign up to set email alerts
|

Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
22
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 20 publications
1
22
0
Order By: Relevance
“…Our own data from an international trial evaluating low-cost high-resolution microendoscopy plus LCE versus LCE alone showed a per-biopsy sensitivity of 97% and a per-patient sensitivity of 100% with LCE alone for the detection of high-grade dysplasia or ESCC. 12 The results from Li et al 6 are therefore intriguing, and a significant departure from all prior studies.…”
mentioning
confidence: 80%
See 2 more Smart Citations
“…Our own data from an international trial evaluating low-cost high-resolution microendoscopy plus LCE versus LCE alone showed a per-biopsy sensitivity of 97% and a per-patient sensitivity of 100% with LCE alone for the detection of high-grade dysplasia or ESCC. 12 The results from Li et al 6 are therefore intriguing, and a significant departure from all prior studies.…”
mentioning
confidence: 80%
“…The most prominent prior study evaluating the sensitivity of LCE for squamous dysplasia and ESCC was done by Dawsey et al 7 in Linxian, China, which is also referenced by Li et al 6 in their current study. In the Linxian study, the reported sensitivity of LCE for the diagnosis of high-grade dysplasia or carcinoma was 96%.…”
mentioning
confidence: 83%
See 1 more Smart Citation
“…Due to the late-stage at diagnosis for most patients, the prognosis of ESCC patients remains poor, with an overall 5-year survival rate of 15-25% [4,5]. Massive efforts have been made to develop diverse methods to detect early cancer, monitor treatment response and predict prognosis [6][7][8][9][10]. To date, nevertheless, works to indentify molecular markers in association with the pathogenesis and response to therapy of ESCC have proved to be essentially unsuccessful [11].…”
Section: Introductionmentioning
confidence: 99%
“…[10][11][12] Two large studies have shown a high sensitivity of LCE compared with biopsy for severe squamous dysplasia and ESCC in high-risk regions of China. 13,14 In this issue of Clinical Gastroenterology and Hepatology, an insightful analysis within the intervention arm of an ongoing, large, cluster-randomized, controlled trial from Lui et al 15 in the Hua county region of China (a high-risk region for ESCC), has contributed significantly to the prior literature in elucidating the testing characteristics of Lugol chromoendoscopy for ESCC and dysplasia in the Asian esophageal cancer belt. The authors found that participants with unstained areas on LCE but biopsies without squamous dysplasia had a higher rate of progression to severe squamous dysplasia, squamous carcinoma in situ, or invasive squamous cell carcinoma than those with mild or moderate dysplasia on nontargeted biopsy and the absence of unstained lesions on Lugol iodine staining.…”
mentioning
confidence: 99%